ERYTECH successfully raises €30 million for expanding its therapeutic indications in oncology and accelerating its clinical developments admERY October 23, 2014 Newsroom ERYTECH announces today the successful completion of a capital increase for a total amount of €30 million. You Might Also Like ERYTECH to Host Third Quarter 2020 Conference Call and Business Update on November 6, 2020 October 29, 2020 ERYTECH to present at upcoming investor conferences May 20, 2013 ERYTECH appoints Dr. Iman El-Hariry as Chief Medical Officer July 15, 2015
ERYTECH to Host Third Quarter 2020 Conference Call and Business Update on November 6, 2020 October 29, 2020
